Fabhalta
Fabhalta is a pharmaceutical drug made by Novartis AG.
Key facts
- Type
- Product
- Category
- Pharmaceutical drug
- Made by
- Novartis AG
- Also known as
- iptacopan
What is being said
Sentiment on Fabhalta is neutral over the past month and strengthening from a month ago; there is no reading for today yet. Most of the conversation is on News and X.
News and X lean bearish.
What is driving the conversation about Fabhalta
Connections of Fabhalta
Made by
People at Novartis AG
- Vasant Narasimhan, Chief Executive Officer, since 2018
Peers of Novartis AG
Frequently asked questions
Who makes Fabhalta?
Fabhalta is made by Novartis AG.
Is sentiment on Fabhalta bullish or bearish right now?
Sentiment on Fabhalta is neutral over the past month on SentiSense. There is no reading for today yet. SentiSense tracks it daily with the SentiSense Score, shown on this page for signed-in readers.
What is driving attention to Fabhalta?
Recent stories driving the conversation include "Novartis Ends Mid-Stage Fabhalta Trial in Lupus Nephritis, Citing Strategic Reasons" (October 16, 2026).
See the live SentiSense Score, mentions and source mix on this page after you sign in, free.
Educational only, not investment advice.